"Thymine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
One of four constituent bases of DNA.
| Descriptor ID |
D013941
|
| MeSH Number(s) |
D03.383.742.698.875.899
|
| Concept/Terms |
Thymine- Thymine
- 5-Methyluracil
- 5 Methyluracil
|
Below are MeSH descriptors whose meaning is more general than "Thymine".
Below are MeSH descriptors whose meaning is more specific than "Thymine".
This graph shows the total number of publications written about "Thymine" by people in this website by year, and whether "Thymine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2005 | 0 | 2 | 2 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2013 | 1 | 1 | 2 |
| 2018 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Thymine" by people in Profiles.
-
Differential ETS1 binding to T:G mismatches within a CpG dinucleotide contributes to C-to-T somatic mutation rate of the IDH2 hotspot at codon Arg140. DNA Repair (Amst). 2022 05; 113:103306.
-
Quantitation of Pyrimidine in Urine by Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry. Methods Mol Biol. 2022; 2546:431-437.
-
Preferential CEBP binding to T:G mismatches and increased C-to-T human somatic mutations. Nucleic Acids Res. 2021 05 21; 49(9):5084-5094.
-
TAS-102 plus bevacizumab: a new standard for metastatic colorectal cancer? Lancet Oncol. 2020 03; 21(3):326-327.
-
Structural basis for preferential binding of human TCF4 to DNA containing 5-carboxylcytosine. Nucleic Acids Res. 2019 09 19; 47(16):8375-8387.
-
Structural basis for effects of CpA modifications on C/EBP? binding of DNA. Nucleic Acids Res. 2019 02 28; 47(4):1774-1785.
-
Leukocytoclastic vasculitis with late-onset Henoch-Sch?nlein purpura after trifluridine/tipiracil treatment. Dermatol Online J. 2018 Oct 15; 24(10).
-
Detecting and interpreting DNA methylation marks. Curr Opin Struct Biol. 2018 12; 53:88-99.
-
Trifluridine-Tipiracil for Previously Treated Metastatic Colorectal Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics. 2018 03; 36(3):285-288.
-
Phase 1 study of cardiac safety of TAS-102 in patients with advanced solid tumors. Cancer Chemother Pharmacol. 2016 06; 77(6):1275-83.